Stockreport

U.S. government to fund up to $500-million for studies on oral, nasal COVID vaccines [Globe and Mail, The (Toronto, Canada)]

Vaxart, Inc.  (VXRT) 
Last vaxart, inc. earnings: 3/19 04:01 pm Check Earnings Report
PDF mid-stage trials evaluating vaccines administered as a nasal spray or pill to protect against symptomatic COVID-19. The funding is part of Project NextGen, a $5-billio [Read more]